SLC5A2 and cancer: Here, we review the current evidence on the role of SGLT2 in cancer and the possible use of SGLT2is as anti-cancer agents, focusing on the four molecules that have been on the market for longer time: canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin.